When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Meningioma

最后审阅: 18 Aug 2025
最后更新: 11 Apr 2025

小结

定义

病史和体格检查

关键诊断因素

  • headache
  • neurologic deficit
  • seizure
  • history of radiation exposure
完整详情

其他诊断因素

  • family history of brain tumor or neurofibromatosis 2 (NF2)
  • history of breast cancer
  • history of exogenous hormone exposure
  • cognitive deficit
  • vertigo/dizziness
完整详情

危险因素

  • ionizing radiation
  • genetic predisposition
  • hormones: endogenous and exogenous
  • head trauma
完整详情

诊断性检查

首要检查

  • MRI brain or spine with and without contrast
完整详情

需考虑的检查

  • CT brain or spine
  • somatostatin receptor PET/CT
  • cerebral angiography
  • histopathology of surgical resection
完整详情

治疗流程

急症处理

good surgical candidate

poor surgical candidate

持续性治疗

recurrent or progressive tumor following initial treatment

撰稿人

作者

Stephen T. Magill, MD, PhD

Assistant Professor

Lou and Jean Malnati Brain Tumor Institute

Robert Lurie Comprehensive Cancer Center

Department of Neurological Surgery

Northwestern University Feinberg School of Medicine

Chicago

IL

Divulgaciones

STM has authored several articles cited in this topic.

Agradecimientos

Dr Stephen T. Magill would like to gratefully acknowledge Professor William T. Couldwell and Dr Jayson A. Neil, previous contributors to this topic.

Divulgaciones

WTC is an author of several references cited in this topic. JAN declares that he has no competing interests.

Revisores por pares

Marc Chamberlain, MD

Professor of Neurology

Moffitt Cancer Center and Research Institute

University of Washington

Seattle

WA

Divulgaciones

MC is an author of several references cited in this topic.

Ian McCutcheon, MD

Professor of Neurosurgery

The University of Texas M. D. Anderson Cancer Center

Houston

TX

Divulgaciones

IM declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

World Health Organization Classification of Tumours Editorial Board. WHO classification of tumours of the central nervous system. 5th Edition. France: IARC; 2021.

Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021 Aug 2;23(8):1231-51.Texto completo  Resumen

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: central nervous system cancers [internet publication].Texto completo

Goldbrunner R, Stavrinou P, Jenkinson MD, et al. EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol. 2021 Nov 2;23(11):1821-34.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad